Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial (Q35537740)
Jump to navigation
Jump to search
scientific article published on June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial |
scientific article published on June 2005 |
Statements
1 reference
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial (English)
1 reference
E F M Wouters
1 reference
D S Postma
1 reference
B Fokkens
1 reference
W C J Hop
1 reference
J Prins
1 reference
A F Kuipers
1 reference
H R Pasma
1 reference
C A J Hensing
1 reference
E C Creutzberg
1 reference
COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group
1 reference
1 June 2005
1 reference
1 reference
60
1 reference
6
1 reference
480-487
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference